The 10 analysts offering 12-month price forecasts for Kura Oncology Inc have a median target of 30.00, with a high estimate of 47.00 and a low estimate of 22.00. The median estimate represents a +115.83% increase from the last price of 13.90.
The current consensus among 11 polled investment analysts is to Buy stock in Kura Oncology Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.57
Reporting Date Mar 14
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.